Does rooibos tea improve cholesterol and blood sugar?

What makes rooibos scientifically interesting is aspalathin, a dihydrochalcone found exclusively in the Aspalathus linearis plant¹. No other commercially available food or drink contains this compound. Aspalathin is a potent antioxidant, but its health relevance goes beyond simple free-radical scavenging.

Research has focused on aspalathin's effects on glucose metabolism and insulin sensitivity. In cell and animal studies, aspalathin has been shown to stimulate glucose uptake in muscle cells and improve insulin secretion from pancreatic beta cells³. These findings have generated interest in rooibos as a supportive dietary choice for people managing blood sugar.

Rooibos also contains nothofagin, orientin, isoorientin, vitexin, and isovitexin -- a flavonoid profile distinct from Camellia sinensis teas².

Low Tannin Advantage

Traditional black and green teas contain significant tannins, which can inhibit iron absorption and cause stomach discomfort in sensitive individuals. Rooibos is notably low in tannins, making it gentler on the stomach and less likely to interfere with mineral absorption¹. This makes it a practical choice for people with iron deficiency or those who drink several cups per day.

Cardiovascular and Metabolic Research

A human intervention study by Marnewick et al. (2011) found that six weeks of rooibos consumption (six cups per day) in adults at risk for cardiovascular disease significantly improved lipid profiles -- LDL cholesterol and triglycerides decreased while HDL cholesterol increased⁴. The study also showed reduced markers of oxidative stress and lipid peroxidation.

Bone Health and Allergy Relief

Preliminary research suggests that rooibos flavonoids may support bone metabolism. In vitro studies have shown that orientin and luteolin (both present in rooibos) can promote osteoblast activity and inhibit osteoclast formation¹. These findings are early-stage but suggest potential relevance for bone health, particularly in postmenopausal populations.

Rooibos has also been traditionally used in South Africa as a remedy for allergies and skin conditions. Some evidence supports an antihistamine-like effect of its flavonoids, though rigorous clinical trials are lacking².

Aspalathin and Metabolic Health

Johnson et al. (2018) provided a comprehensive review of aspalathin's therapeutic potential for metabolic syndrome³. The compound has demonstrated multiple relevant mechanisms in preclinical models:

• Glucose uptake: Aspalathin increases glucose uptake in muscle cells via AMPK activation, independent of insulin signaling.
• Insulin secretion: It enhances glucose-stimulated insulin secretion from pancreatic beta cells.
• Lipid metabolism: Aspalathin suppresses hepatic lipogenesis and reduces triglyceride accumulation.
• Anti-inflammatory: It attenuates NF-kB-mediated inflammation in adipose tissue.

These effects have been demonstrated primarily in cell culture and rodent models. While the mechanistic evidence is robust, human clinical trials specifically testing aspalathin supplementation are still limited. The metabolic effects observed with whole rooibos tea consumption⁴ may be attributable to aspalathin working synergistically with other rooibos flavonoids.

Cardiovascular Evidence

The Marnewick et al. (2011) trial is the most cited human study on rooibos⁴. Forty adults at risk for heart disease consumed six cups of rooibos daily for six weeks in a controlled study. Key findings:

• LDL cholesterol decreased significantly (p < 0.001)
• Triglycerides decreased significantly
• HDL cholesterol increased significantly
• Plasma conjugated dienes (a marker of lipid peroxidation) decreased
• Glutathione (an endogenous antioxidant) levels improved

The effect sizes were clinically meaningful, comparable to moderate dietary interventions. However, six cups per day represents high consumption, and whether lower doses produce proportional benefits is unknown.

Bioavailability Considerations

Joubert and de Beer (2011) addressed the critical question of whether rooibos compounds are bioavailable when consumed as tea^1,2. Aspalathin is absorbed in the gut and detectable in plasma, but its bioavailability is relatively low. However, metabolites of aspalathin may retain biological activity, and the consistent results from whole-tea studies suggest that sufficient quantities reach target tissues at typical consumption levels.

Notably, unfermented ("green") rooibos retains significantly more aspalathin than the traditional fermented ("red") rooibos. The fermentation process oxidizes much of the aspalathin. For those seeking maximum antioxidant benefit, green rooibos is the better choice, though fermented rooibos still contains meaningful amounts of bioactive compounds².

Limitations

The evidence base for rooibos health effects is smaller than for green or black tea. Most mechanistic work comes from a concentrated group of South African research institutions, and independent replication would strengthen the findings. Human trials are few and generally small. The bone health and allergy claims rest on preclinical evidence and traditional use rather than clinical data.

Rooibos is considered very safe. No significant adverse effects have been reported in clinical studies or from its long history of consumption in South Africa. Rare case reports of hepatotoxicity exist but have not established causation, and the overall safety profile is reassuring¹.